Wissenschaftliche Arbeiten
Prof. Dr. Gül Başaran
139 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.
-
2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)
Annals of Oncology, 2020
DOI 10.1016/j.annonc.2020.08.1314 Frei zugänglicher VolltextQuelle: OpenAlex
-
COVID Pandemisi Sürecinde Meme Kanserinde Antihormon Tedavi
Türkiye Klinikleri COVID - 19, 2020
Quelle: OpenAlex
-
Abstract P5-11-19: Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey
Cancer Research, 2020
DOI 10.1158/1538-7445.sabcs19-p5-11-19 Quelle: OpenAlex
-
Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.
Journal of Clinical Oncology, 2020
DOI 10.1200/jco.2020.38.15_suppl.e13055 Quelle: OpenAlex
-
Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak
Turkish Journal of Surgery, 2020
DOI 10.5578/turkjsurg.4815 PMID 33015560 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Yaşlı Hastalarda Meme Kanseri Tedavisine Yaklaşım
Turkiye Klinikleri Medical Oncology - Special Topics, 2020
Quelle: OpenAlex
-
APPROACH TO BREAST CANCER TREATMENT IN ELDERLY PATIENTS
Turkiye Klinikleri eBooks, 2020
DOI 10.5336/978-625-401-191-7_p77 Quelle: OpenAlex
-
Adjuvant Therapy for HER-2-Positive Early Breast Cancer
Springer eBooks, 2019
DOI 10.1007/978-3-030-16792-9_9 Quelle: OpenAlex
-
THE EFFECT OF HYPERTENSION THE TREATMENT OF DOXAZOSIN ON BENIGN PROSTATE HYPERPLASIA PATIENTS
Urology Research and Practice, 2019
Frei zugänglicher VolltextQuelle: OpenAlex
-
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
Cancer Chemotherapy and Pharmacology, 2018
DOI 10.1007/s00280-018-3712-7 PMID 30377778 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results
Annals of Oncology, 2018
DOI 10.1093/annonc/mdy272.315 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Türkiye’de Metastatik Meme Kanserinde HER2 hedefli tedavide Pertuzumab kullanımı erken dönem güvenlilik verileri
Kocaeli Üniversitesi - AVESİS, 2018
Quelle: OpenAlex
-
Türkiye’xxde metastatik meme kanserinde Her2 hedefli tedavide pertuzumab kullanımı erken dönem güvenlilik verileri
Kocaeli Üniversitesi - AVESİS, 2018
Quelle: OpenAlex
-
Türkiye'de Metastatik Meme Kanserinde HER-2 Hedefli Tedavide Pertuzumab Kullanımının Erken Dönem Güvenlik Verileri
Van Yüzüncü Yıl University Academic Data Management System, 2018
Quelle: OpenAlex
-
Gebelik ve Meme Kanseri (TOG Meme ve Genç Araştırmacılar Grubu çalışması)
Kocaeli Üniversitesi - AVESİS, 2018
Quelle: OpenAlex
-
Cost of Treatment of HR+/HER2- Post Menopausal Advanced/Metastatic Breast Cancer Patients in Turkey
Value in Health, 2016
DOI 10.1016/j.jval.2016.03.1569 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Adjuvant Therapy for HER2-Positive Early Breast Cancer
Springer eBooks, 2016
DOI 10.1007/978-3-319-26012-9_9 Quelle: OpenAlex
-
Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials
Critical Reviews in Oncology/Hematology, 2015
DOI 10.1016/j.critrevonc.2015.10.006 PMID 26603345 38 Zitationen (Europe PMC) Quelle: OpenAlex
-
Prognostic role of progesterone receptor (PR) expression by immunohistochemistry (IHC) in relation to Oncotype recurrence scores (RS).
Journal of Clinical Oncology, 2015
DOI 10.1200/jco.2015.33.15_suppl.e11589 Quelle: OpenAlex
-
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)
European Journal of Cancer, 2015
DOI 10.1016/j.ejca.2015.10.012 PMID 26724641 36 Zitationen (OpenAlex) Quelle: OpenAlex
-
Mutation analysis of the BRCA1 and BRCA2 genes in Turkish patients with breast cancer.
Journal of Clinical Oncology, 2015
DOI 10.1200/jco.2015.33.15_suppl.e12536 Quelle: OpenAlex
-
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
Meme sağlığı dergisi/Meme sağlığı dergisi, 2014
DOI 10.5152/tjbh.2014.1904 PMID 28331673 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience
Asian Pacific Journal of Cancer Prevention, 2014
DOI 10.7314/apjcp.2014.15.1.117 PMID 24528011 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.
Europe PMC (PubMed Central), 2014
PMID 24995112 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Systemic rituximab immunotherapy in the management of primary ocular adnexal lymphoma: Single institution experience.
Journal of Clinical Oncology, 2014
DOI 10.1200/jco.2014.32.15_suppl.e19503 2 Zitationen (OpenAlex) Quelle: OpenAlex
-
Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)
Breast Cancer, 2013
DOI 10.1007/s12282-013-0506-y PMID 24338610 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
The Breast, 2013
DOI 10.1016/j.breast.2013.07.048 PMID 23954396 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Hipokalemik Paralizi ile Klinik Belirti Veren Adrenokortikal Karsinom Olgusu
Acibadem University Open Access Repository, 2013
Frei zugänglicher VolltextQuelle: OpenAlex
-
349 High Ki67 Values Are Significantly Correlated with Oncotype DX Scores
European Journal of Cancer, 2012
DOI 10.1016/s0959-8049(12)70415-x Quelle: OpenAlex
-
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.
Journal of Clinical Oncology, 2012
DOI 10.1200/jco.2012.30.15_suppl.e16015 Frei zugänglicher VolltextQuelle: OpenAlex
-
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.
Kocaeli Üniversitesi - AVESİS, 2012
Quelle: OpenAlex
-
Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer
Biomarkers, 2012
DOI 10.3109/1354750x.2012.738250 PMID 23116493 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK).
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.e12007 Frei zugänglicher VolltextQuelle: OpenAlex
-
Primary breast mantle cell lymphoma with atypical relapse patterns.
PubMed, 2011
PMID 21674874 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study.
PubMed, 2011
PMID 21766495 Frei zugänglicher VolltextQuelle: OpenAlex
-
The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; multicenter observational study.
PubMed, 2011
PMID 22331719 3 Zitationen (Europe PMC) Quelle: OpenAlex
-
TÜRKİYE’xxDE MEME KANSERLİ HASTALARIN TANI VE TEDAVİ YÖNTEMLERİNE ULAŞIM HIZI ÇOK MERKEZLİ GÖZLEMSEL ÇALIŞMA.
Dspace Repository (Marmara Üniversitesi), 2011
2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.e18010 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Correlation of high FDG uptake in PET/CT with poor prognosis in metastatic gastric adenocarcinoma.
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.e14668 Frei zugänglicher VolltextQuelle: OpenAlex
-
Clinical/pathologic characteristics of diabetic patients with early breast cancer (BC) and their survival outcome.
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.e11019 Frei zugänglicher VolltextQuelle: OpenAlex
-
Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.629 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID
-
Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.e13079 1 Zitation (OpenAlex) Quelle: ORCID
-
The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients.
Journal of Clinical Oncology, 2011
DOI 10.1200/jco.2011.29.15_suppl.e11042 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey
Medical Oncology, 2010
DOI 10.1007/s12032-010-9463-x PMID 20306160 17 Zitationen (Europe PMC) Quelle: OpenAlex
-
Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?
Medical Oncology, 2010
DOI 10.1007/s12032-010-9516-1 PMID 20390469 14 Zitationen (Europe PMC) Quelle: OpenAlex
-
498 Clinical outcome of Turkish metastatic breast cancer patients with currently available treatment modalities. Single center experience
European Journal of Cancer Supplements, 2010
DOI 10.1016/s1359-6349(10)70519-x Frei zugänglicher VolltextQuelle: OpenAlex
-
Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Alone in Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma: Do We Really Have Robust Data?
Journal of Clinical Oncology, 2010
DOI 10.1200/jco.2010.29.0304 PMID 20606082 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
E7. Taxanes as adjuvant therapy for breast cancer
European Journal of Cancer Supplements, 2010
DOI 10.1016/s1359-6349(10)70011-2 Frei zugänglicher VolltextQuelle: OpenAlex
-
Dalakta ve terminal ileumda gelişen malign melanom metastazı, cerrahi tedavi sonrası oluşan perineal metastaz: Olgu sunumu
Kocaeli Üniversitesi - AVESİS, 2010
Quelle: OpenAlex
-
A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion.
PubMed, 2009
PMID 19650184 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex